Predicting Severe Outcomes Among Children Hospitalized With Community-acquired Pneumonia
- Conditions
- ChildPneumoniaPrognosis
- Registration Number
- NCT05744609
- Lead Sponsor
- Children's Hospital of Fudan University
- Brief Summary
In this study, investigators aimed to develop and validate a risk score to predict severe outcomes (e.g., mortality and ICU admission) in children who were admitted to the Children's Hospital of Fudan University between 2017 and 2022 due to community-acquired pneumonia (CAP). The objectives were as follows.
1. Develop a risk prediction model based on demographic, comorbidity, clinical characteristics, laboratory data, and chest radiographic reports to predict severe outcomes among children hospitalized with CAP;
2. Develop a risk scoring system and determine the cut-off point;
3. Externally validate the easy-to-use risk score.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 6000
- Aged between 29 days and 18 years old;
- Admitted to hospital with signs or symptoms of acute infection (eg, fever) and acute respiratory illness (eg, cough), and radiographic evidence of pneumonia.
- Pneumonia developed 48 hours after admission or intubation;
- Chronic pneumonia, tuberculosis, tracheobronchial foreign bodies, aspiration pneumonia, parasitic lung disease, and diffuse pulmonary interstitial/parenchyma disease.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method in-hospital mortality from admission to discharge, an average of 7 days in-hospital mortality among children hospitalized with CAP
- Secondary Outcome Measures
Name Time Method admission to ICU from admission to discharge, an average of 7 days admission to a intensive care unit for over 24 hours
septic shock from admission to discharge, an average of 7 days occurrence of septic shock during admission
treatment for severe pneumonia from admission to discharge, an average of 7 days vasoactive agents, positive-pressure ventilation or chest drainage, or extracorporeal membrane oxygenation
Trial Locations
- Locations (1)
Children's Hospital of Fudan University
🇨🇳Shanghai, Shanghai, China